Drug Database
Back to search

United States· US:50090-5846_1aaa01b0-cea2-49cb-b15e-6391881abcc4

Methocarbamol

A methocarbamol product containing methocarbamol, registered in United States by A-S Medication Solutions. The same ATC class is registered in 12 of our 19 countries.

ATC M03BA03US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedMethocarbamolATCM03BA03REGISTER NO.US:50090-5846_1aaa01b…PACKS LISTED4CHECKEDJune 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about methocarbamolAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Methocarbamol is registered in 12 of 19 countries.

Countries holding a registration under ATC M03BA03 (methocarbamol), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 7 of them publish a price we can compare per daily dose
Search methocarbamol products by name

Methocarbamol · ATC M03BA03

12 / 19 countries

  • Canada
  • Czechiaprice
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Japan
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of methocarbamol costs, country by country.

Normalised to the WHO defined daily dose (3 g), so markets compare like for like.

  • United States: $0.17 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Methocarbamol · price per daily dose (3 g)

USD · FX 28 Sept 2026

  • US United States$0.17 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
METHOCARBAMOL
Manufacturer
A-S Medication Solutions
Country
United States (US)
ATC code
M03BA03
ATC class
Methocarbamol
Defined daily dose
3 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
June 26, 2026

Packs & prices · 4

  • ndc11
    5009058460
    10 TABLET in 1 BOTTLE (50090-5846-0)
  • ndc11
    5009058464
    90 TABLET in 1 BOTTLE (50090-5846-4)
  • ndc11
    50090-5846-0
  • ndc11
    50090-5846-4

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

169 interactions on record for methocarbamol.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check methocarbamol against other medicinesHow interaction checks work

Methocarbamol · interactions on record

169 records

  • 4 severe
  • 53 moderate
  • 112 info

Most severe, free to view

  • MorphineN02AA01severe
  • MorphinN07BC09severe
  • HydrocodoneR05DA03severe
  • CodeineR05DA04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Methocarbamol in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All methocarbamol products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Austria · Methocarbamol Kwizda
  • Czechia · Dolirobax
  • Germany · Methoca, Methocarbamol Al
  • Spain · Dolirobax, Molitrem
  • France · Lumirelax, Methocarbamol Arrow
  • United Kingdom (Northern Ireland) · Methocarbamol Activase Pharmaceuticals, Methocarbamol Amarox
  • Hungary · Dolirobax Tabletta
  • Luxembourg · Methocarbamol Micro Labs
  • Malta · Rolaxifor
  • Poland · Methocarbamol Espefa
  • Portugal · Robaxisal, Zelaz
  • Slovakia · Dolirobax

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c130b1ac-2bfb-48dc-9ca3-ad2c6005312e
GET /v1/drugs/c130b1ac-2bfb-48dc-9ca3-ad2c6005312e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "500",
  "substance": "METHOCARBAMOL",
  "productndc": "50090-5846",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA040489",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about methocarbamol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console